Analysis
| Earnings estimate |
Current quarter (Dec 2025) |
Next quarter (Mar 2026) |
Current year (Dec 2025) |
Next year (Dec 2026) |
|---|---|---|---|---|
| Number of analysts | 12 | 4 | 39 | 39 |
| Average estimate | 6.98 | 7.62 | 27.83 | 31.42 |
| Low estimate | 6.59 | 7.17 | 25.63 | 28.90 |
| High estimate | 7.50 | 8.09 | 29.03 | 33.91 |
| Last year EPS | 5.91 | 6.58 | 23.51 | 27.83 |
| Revenue estimate |
Current quarter (Dec 2025) |
Next quarter (Mar 2026) |
Current year (Dec 2025) |
Next year (Dec 2026) |
|---|---|---|---|---|
| Number of Analysts | 17 | 5 | 40 | 52 |
| Avg. estimate | 194.84B | 198.48B | 752.26B | 825.60B |
| Low estimate | 191.98B | 193.83B | 747.36B | 772.54B |
| High estimate | 198.76B | 206.70B | 756.35B | 859.37B |
| Last year sales | 172.45B | 180.02B | 660.26B | 752.26B |
| Sales growth | 0.13 | 0.10 | 0.14 | 0.10 |
| EPS trend |
Current quarter (Dec 2025) |
Next quarter (Mar 2026) |
Current year (Dec 2025) |
Next year (Dec 2026) |
|---|---|---|---|---|
| Current estimate | 6.98 | 7.62 | 27.83 | 31.42 |
| 7 days ago | 7.09 | 7.78 | 27.82 | 31.43 |
| 30 days ago | 7.09 | 7.78 | 27.53 | 31.22 |
| 60 days ago | 7.09 | 7.78 | 27.52 | 31.19 |
| 90 days ago | 7.09 | 7.78 | 27.45 | 31.07 |
| EPS revisions |
Current quarter (Dec 2025) |
Next quarter (Mar 2026) |
Current year (Dec 2025) |
Next year (Dec 2026) |
|---|---|---|---|---|
| Up last 7 days | 1 | 1 | 7 | 15 |
| Up last 30 days | 1 | 1 | 25 | 18 |
| Down last 7 days | 0 | 0 | 0 | 0 |
| Down last 30 days | 5 | 1 | 2 | 9 |
| Growth estimates | |
|---|---|
| Current qtr (Nov 2025) | 0.180% |
| Next qtr. (Feb 2026) | 0.157% |
| Current year (2025) | 0.184% |
| Next 5 years (per annum) | 0.149% |
| Past 5 years (per annum) | 0.180% |
Recommendation
Buy